Cargando…
Treat‐to‐target and sequencing therapies in Crohn's disease
Crohn's disease (CD) is a chronic immune‐mediated inflammatory condition which can negatively impact a patient's quality of life. The traditional management strategy for CD has focused on symptomatic control, however, this approach fails to prevent organ damage and to change the progressiv...
Autores principales: | Garcia, Nicole M., Cohen, Nathaniel A., Rubin, David T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752313/ https://www.ncbi.nlm.nih.gov/pubmed/36507876 http://dx.doi.org/10.1002/ueg2.12336 |
Ejemplares similares
-
Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry
por: Lichtenstein, Gary R, et al.
Publicado: (2012) -
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease
por: Buisson, Anthony, et al.
Publicado: (2021) -
A microbial signature for Crohn's disease
por: Pascal, Victoria, et al.
Publicado: (2017) -
Bacterial protein signals are associated with Crohn’s disease
por: Juste, Catherine, et al.
Publicado: (2014) -
Adalimumab for the treatment of fistulas in patients with Crohn’s disease
por: Colombel, J-F, et al.
Publicado: (2009)